Abstract
Survival analysis techniques were used in estimating lifetime inpatient utilization among patients diagnosed with acquired immunodeficiency syndrome (AIDS) using data on 863 members of the Kaiser Permanente Medical Care Program in the Northern California Region diagnosed with AIDS between January 1, 1981 and June 30, 1987. Using information on both deceased and living patients, we estimated means of 40.3 lifetime inpatient days and 3.3 hospitalizations among all AIDS patients. Those presenting with Kaposi's sarcoma experienced a mean of 7.6 fewer lifetime inpatient days than those presenting with Pneumocystis carinii pneumonia (95% confidence interval = .61, 14.6) and a mean of 11.0 (3.9, 18.6) fewer inpatient days than all other AIDS patients. Older patients had fewer hospital admissions than younger ones. Year of diagnosis does not appear to be related to lifetime utilization, and there is an indication that increased survival has been accompanied by decreased inpatient utilization intensity as measured on a per person-year basis. We recommend the use of survival analysis methods in the study of utilization among groups of patients with incomplete follow-up.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrulis D. P., Beers V. S., Bentley J. D., Gage L. S. The provision and financing of medical care for AIDS patients in US public and private teaching hospitals. JAMA. 1987 Sep 11;258(10):1343–1346. [PubMed] [Google Scholar]
- Arellano M. G., Petersen G. R., Petitti D. B., Smith R. E. The California Automated Mortality Linkage System (CAMLIS). Am J Public Health. 1984 Dec;74(12):1324–1330. doi: 10.2105/ajph.74.12.1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bacchetti P., Osmond D., Chaisson R. E., Dritz S., Rutherford G. W., Swig L., Moss A. R. Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis. 1988 May;157(5):1044–1047. doi: 10.1093/infdis/157.5.1044. [DOI] [PubMed] [Google Scholar]
- Bloom D. E., Carliner G. The economic impact of AIDS in the United States. Science. 1988 Feb 5;239(4840):604–610. doi: 10.1126/science.3277273. [DOI] [PubMed] [Google Scholar]
- Hardy A. M., Rauch K., Echenberg D., Morgan W. M., Curran J. W. The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA. 1986 Jan 10;255(2):209–211. [PubMed] [Google Scholar]
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
- Scitovsky A. A., Cline M., Lee P. R. Medical care costs of patients with AIDS in San Francisco. JAMA. 1986 Dec 12;256(22):3103–3106. [PubMed] [Google Scholar]
- Seage G. R., 3rd, Landers S., Barry A., Groopman J., Lamb G. A., Epstein A. M. Medical care costs of AIDS in Massachusetts. JAMA. 1986 Dec 12;256(22):3107–3109. [PubMed] [Google Scholar]